Back to search

Tumour necrosis factor- α and transforming growth factor- β are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL-2-mediated neovascularization

Data up to Jan 2025

Published2000
Citations54
References39

Total Citations Per Year

Abstract

References (39)

Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

1984 • 3,268 citations

Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells

1985 • 1,687 citations

Transforming Growth Factor-β: Biological Function and Chemical Structure

1986 • 1,198 citations

bcl-2 Protein in Non-Small-Cell Lung Carcinoma

1993 • 684 citations

Tumor interactions with the vasculature: angiogenesis and tumor metastasis

1990 • 598 citations

American Joint Committee on Cancer

2015 • 387 citations

Dual role of tumor necrosis factor-alpha in angiogenesis.

1992 • 342 citations

Angiogenesis as a Prognostic Indicator of Survival in Non-Small-Cell Lung Carcinoma: a Prospective Study

1997 • 309 citations

Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression.

1993 • 254 citations

Association of tumour necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma

1998 • 206 citations

Expression of BCL-2 protein enhances the survival of mouse fibrosarcoid cells in tumor necrosis factor-mediated cytotoxicity.

1993 • 163 citations

The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium

1996 • 156 citations

Transforming growth factor beta1 in ductal carcinoma in situ and invasive carcinomas of the breast

1992 • 154 citations

Excessive production of transforming growth-factor β1 can play an important role in the development of tumorigenesis by its action for angiogenesis: validity of neutralizing antibodies to block tumor growth

1992 • 147 citations

Growth regulation of human breast carcinoma occurs through regulated growth factor secretion

1987 • 139 citations

Expression of tumour necrosis factor (TNFα) and its receptors in benign and malignant breast tissue

1994 • 126 citations

In transit metastases of malignant melanoma treated by high dose rTNFα in combination with interferon‐γ and melphalan in isolation perfusion

1992 • 124 citations

Localization of transforming growth factor-β isotypes in lesions of the human breast

1992 • 107 citations

bcl2 and p53 regulate vascular endothelial growth factor (VEGF)-mediated angiogenesis in non-small cell lung carcinoma

1998 • 99 citations

Evaluation of bcl-2 protein expression and 14;18 translocation as prognostic markers in follicular lymphoma

1992 • 97 citations

The prognostic significance of transforming growth factors in human breast cancer

1993 • 90 citations

Transforming growth factor beta1 induces angiogenesis in vivo with a threshold pattern.

1996 • 85 citations

A phase II trial of recombinant tumor necrosis factor in patients with advanced colorectal carcinoma

1990 • 79 citations

Expression of tumour necrosis factor α and its receptors in carcinoma of the breast

1994 • 75 citations

Immunohistochemical demonstration of growth factors, TGF-alpha, TGF-beta, IGF-I and neu oncogene product in benign and malignant human breast tissues.

1990 • 65 citations

Effect of recombinant monokines, lymphokines, and other agents on clonal proliferation of human lung cancer cell lines.

1987 • 63 citations

Potential role ofbcl-2 as a suppressor of tumour angiogenesis in non-small-cell lung cancer

1997 • 57 citations

Functional characterization of tumor‐infiltrating lymphocytes, lymph‐node lymphocytes and peripheral‐blood lymphocytes from patients with breast cancer

1991 • 44 citations

Induction of lymphokine-activated killer cytotoxicity with interleukin-2 and tumor necrosis factor-? against primary lung cancer targets

1989 • 44 citations

The World Health Organization. Histological typing of lung tumours.

1982 • 33 citations

Prognostic significance of tumor necrosis factors and their receptors in nonsmall cell lung carcinoma

1998 • 33 citations

Bcl-2 protein and prognosis in patients with potentially curable non-small-cell lung cancer

1998 • 30 citations

Prognostic significance of TGF-beta 1 and TGF-beta 2 expressions in female breast cancer.

1995 • 27 citations

Quantitation by competitive PCR assay of vascular endothelial growth factor in non-small cell lung carcinomas.

1999 • 20 citations

Anti‐proliferative effects of tumor necrosis factor, gamma interferon and 5‐fluorouracil on human colorectal carcinoma cell lines

1990 • 20 citations

Tumor Necrosis Factor in Advanced Colorectal Cancer: A Phase II Study

1990 • 15 citations

Colony Inhibitory Effect of Recombinant Human Tumor Necrosis Factor (rH-TNF) and/or Recombinant Human Interferon (rH-IFN)-α -β and -γ on Human Lung Cancer Cell Lines

1987 • 12 citations

Antitumor Effect of Recombinant Human Interleukin‐1β Alone and in Combination with Natural Human Tumor Necrosis Factor‐α

1990 • 10 citations

Potential role of bcl-2 as a suppressor of tumour angiogenesis in non- small-cell lung cancer

1997 • 7 citations

Cited By (0)

Loading...
Tumour necrosis factor- α and transforming growth factor- β are significantly associated… (2000) – British Journal of Cancer | Metascience Observatory Explorer